CD21 Antibody, anti-human, APC, REAfinity™ 130-115-611 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD21 Antibody, anti-human, APC, REAfinity™

Miltenyi Biotec's CD21 Antibody, anti-human, APC, REAfinity™ is a Human monoclonal antibody. The CD21 Antibody, anti-human, APC, REAfinity™ was generated using Cr2 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD21 Antibody, anti-human, APC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-115-611
Quantity30 tests in 60 µL
ApplicationsFlow cytometry
Conjugate/TagAPC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman, other
IsotypeIgG1
CloneREA940
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Clonalitymonoclonal
Concentration1:50
ModificationsRecombinantly engineered
NCBI Full Gene Namecomplement C3d receptor 2
NCBI Gene AliasesC3DR, CD21, CR, CVID7, SLEB9
TargetCD21
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammationJournal of immunology (Baltimore, Md. : 1950)August 15, 2005Gueders MM, Balbin M, Rocks N, Foidart JM, Gosset P, Louis R, Shapiro S, Lopez-Otin C, Noël A, Cataldo DD.

(2) The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigensJournal of immunology (Baltimore, Md. : 1950)July 1, 2001Cherukuri A, Cheng PC, Pierce SK.

(3) Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoproteinInternational immunologyAugust 1, 1998Braun M, Melchers I, Peter HH, Illges H.

(4) Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infectionThe Journal of general virologyDecember 1, 1996Roberts ML, Luxembourg AT, Cooper NR.

Be the First to Write a Review!